Primary study · included by 1 review

Postoperative bleeding risk for oral surgery under continued rivaroxaban anticoagulant therapy

Hanken 2016 · Hanken Henning, Gröbe Alexander, Heiland Max, et al. · Clinical Oral Investigations · 2015

Included by

Outcome this study informsPooled effectEvidenceCertainty
Postoperative bleeding within three weeks of dental implant placement
Continued antithrombotic therapy with local hemostatic measures vs Controls not receiving antithrombotic therapy · Within three weeks postoperatively
RR 4.47 [2.35, 8.51]8 studies · 1792 participantsGRADE not reported
Postoperative bleeding within three weeks of dental implant placement
Continued antithrombotic therapy with local hemostatic measures vs Controls not receiving antithrombotic therapy · Within three weeks postoperatively
RR 1.61 [0.93, 2.79]4 studies · 954 participantsGRADE not reported

1 including review in total.